drugset / Trial / NCT05433428
Metabolomic Profile in Dry Eye Syndrome Patients.
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective is to determine possible implications of deviant tear film quality for optimal refractive precision in patients scheduled for cataract surgery. The study consist of three separate arms where cataract patients will be separated in to Dry Eye Disease (DED) positive and negative groups. The DED positive group will be further subdivided into two different treatment groups (with focus on prolonged use of lubricant and preservative free eye drops). Tear film samples will be taken before treatment, after treatment and after surgical treatment and compared.
Timeline
- Start
- 2020-08-03
- Primary completion
- 2023-01-10
- Completion
- 2023-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dexamethasone | Small molecule | 0.1 % | Topical |
| Subject | Diclofenac | Other / unclassified | 1 mg/ml | Topical |
| Subject | Thealoz Duo | Unknown | — | — |
| Background | Dexamethasone | Small molecule | 1 mg/ml | — |
| Background | Nepafenac | Other / unclassified | 3 mg/ml | — |